{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:30:40Z","timestamp":1791225040883,"version":"4.1.0"},"reference-count":91,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>The demand for homologous blood transfusions has reached an unprecedented level, driven by a declining donor population and the ever-increasing need for blood products. While significant advancements have been made in medical equipment and techniques, a critical gap remains in developing an effective alternative to conventional blood transfusion. Medical research to find a proper blood substitute involves many previous experiments. The search for a blood substitute has been ongoing for patients for whom human blood is unavailable, with a few products showing promise in this field. Recent advancements in medical innovation have begun to address this challenge, notably through the development of artificial oxygen carriers (AOCs). These laboratory-synthesized alternatives to traditional blood transfusions offer a means of bypassing the need for human blood, particularly packed red blood cell (pRBC) transfusions. While AOCs fulfill the singular, critical role of in vivo oxygen delivery, the term is frequently used interchangeably with the broader concept of artificial blood. Various AOC products are currently in different stages of clinical development. Most Notable examples include Perftoran, which has been approved in Russia, Kazakhstan, Ukraine, the Kyrgyz Republic, and Mexico and has been administered to over 35,000 patients. Another significant product, Hemopure, has received clinical use approval in South Africa and Russia and has obtained expanded use approval from the United States Food and Drug Administration (USFDA). This article examines the landscape of AOCs, including their preparation methods, available products, regulatory approval status, current applications, limitations, and potential for future use in medical practice. This review article offers an overview of the different types of AOCs currently available, focusing on their clinical development for human use.<\/jats:p>","DOI":"10.1097\/bs9.0000000000000249","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T15:00:49Z","timestamp":1757948449000},"page":"e00249","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["The evolution of artificial red blood cells and recent advances in state-of-the-art oxygen carrier technologies: a narrative review"],"prefix":"10.1097","volume":"7","author":[{"given":"Trasha","family":"Shetty","sequence":"first","affiliation":[{"name":"CTVS Department, AIIMS, Rishikesh, Uttarakhand 249203, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anshuman","family":"Darbari","sequence":"additional","affiliation":[{"name":"CTVS Department, AIIMS, Rishikesh, Uttarakhand 249203, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,12]]},"reference":[{"issue":"1S Suppl 1","key":"R1-20250915","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/SHK.0000000000001009","article-title":"Hemoglobin-based oxygen carriers: current state-of-the-art and novel molecules.","volume":"52","author":"Sen Gupta","year":"2019","journal-title":"Shock"},{"issue":"8","key":"R2-20250915","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1525-1594.2009.00944.x","article-title":"Perfluorocarbon-based oxygen carriers: review of products and trials.","volume":"34","author":"Castro","year":"2010","journal-title":"Artif Organs"},{"key":"R3-20250915","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4137\/CMBD.S38461","article-title":"Artificial blood substitutes: first steps on the long route to clinical utility.","volume":"9","author":"Moradi","year":"2016","journal-title":"Clin Med Insights Blood Disord"},{"issue":"1","key":"R4-20250915","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.15190\/d.2020.1","article-title":"Artificial blood: the history and current perspectives of blood substitutes.","volume":"8","author":"Khan","year":"2020","journal-title":"Discoveries (Craiova)"},{"issue":"1S Suppl 1","key":"R5-20250915","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1097\/TA.0000000000002250","article-title":"Artificial oxygen carriers and red blood cell substitutes: a historic overview and recent developments toward military and clinical relevance.","volume":"87","author":"Bialas","year":"2019","journal-title":"J Trauma Acute Care Surg"},{"key":"R6-20250915","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1469-185X.1937.tb01222.x","article-title":"Blood substitutes.","volume":"12","author":"Amberson","year":"1937","journal-title":"Biol Rev"},{"issue":"1","key":"R7-20250915","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/1871525717666190617120045","article-title":"Artificial blood: a futuristic dimension of modern day transfusion sciences.","volume":"17","author":"Haldar","year":"2019","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"issue":"9","key":"R8-20250915","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1525-1594.2004.07345.x","article-title":"Artificial oxygen carriers as red blood cell substitutes: a selected review and current status.","volume":"28","author":"Kim","year":"2004","journal-title":"Artif Organs"},{"key":"R9-20250915","doi-asserted-by":"crossref","first-page":"100927","DOI":"10.1016\/j.blre.2022.100927","article-title":"A new era in oxygen therapeutics? From perfluorocarbon systems to haemoglobin-based oxygen carriers.","volume":"54","author":"Charbe","year":"2022","journal-title":"Blood Rev"},{"issue":"1","key":"R10-20250915","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/jfb8010011","article-title":"Comparison of the pharmacokinetic properties of hemoglobin-based oxygen carriers.","volume":"8","author":"Taguchi","year":"2017","journal-title":"J Funct Biomater"},{"issue":"6","key":"R11-20250915","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1046\/j.1537-2995.1990.30690333482.x","article-title":"Characterization of a pyridoxalated hemoglobin-polyoxyethylene conjugate as a physiologic oxygen carrier.","volume":"30","author":"Yabuki","year":"1990","journal-title":"Transfusion"},{"issue":"7","key":"R12-20250915","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1074\/jbc.M609955200","article-title":"Structural basis of peroxide-mediated changes in human hemoglobin: a novel oxidative pathway.","volume":"282","author":"Jia","year":"2007","journal-title":"J Biol Chem"},{"issue":"6","key":"R14-20250915","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3109\/21691401.2012.762370","article-title":"Carbon monoxide form of PEGylated hemoglobin protects myocardium against ischemia\/reperfusion injury in diabetic and normal mice.","volume":"41","author":"Ananthakrishnan","year":"2013","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"1","key":"R15-20250915","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/btpr.2380","article-title":"A PEGylated bovine hemoglobin as a potent hemoglobin-based oxygen carrier.","volume":"33","author":"Wang","year":"2017","journal-title":"Biotechnol Prog"},{"issue":"6","key":"R16-20250915","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1021\/bc025546k","article-title":"Effect of Hb-encapsulation with vesicles on H2O2 reaction and lipid peroxidation.","volume":"13","author":"Takeoka","year":"2002","journal-title":"Bioconjug Chem"},{"issue":"2","key":"R17-20250915","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1525-1594.2008.00699.x","article-title":"Liposome-encapsulated hemoglobin, TRM-645: current status of the development and important issues for clinical application.","volume":"33","author":"Kaneda","year":"2009","journal-title":"Artif Organs"},{"issue":"4","key":"R18-20250915","doi-asserted-by":"crossref","first-page":"BSR20180370","DOI":"10.1042\/BSR20180370","article-title":"Comparison of the oxidative reactivity of recombinant fetal and adult human hemoglobin: implications for the design of hemoglobin-based oxygen carriers.","volume":"38","author":"Simons","year":"2018","journal-title":"Biosci Rep"},{"issue":"1","key":"R20-20250915","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12967-020-02403-y","article-title":"Human induced pluripotent stem cell line banking for the production of rare blood type erythrocytes.","volume":"18","author":"Park","year":"2020","journal-title":"J Transl Med"},{"key":"R21-20250915","doi-asserted-by":"crossref","first-page":"a011601","DOI":"10.1101\/cshperspect.a011601","article-title":"Erythropoiesis: development and differentiation.","volume":"3","author":"Dzierzak","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R22-20250915","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13287-023-03367-8","article-title":"Immortalized erythroid cells as a novel frontier for in vitro blood production: current approaches and potential clinical application.","volume":"14","author":"Cervellera","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"R23-20250915","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/14712598.2017.1316713","article-title":"Advances in umbilical cord blood cell therapy: the present and the future.","volume":"17","author":"Berglund","year":"2017","journal-title":"Expert Opin Biol Ther"},{"key":"R24-20250915","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1186\/s13287-020-01998-9","article-title":"Differentiation of human induced pluripotent stem cells into erythroid cells.","volume":"11","author":"Ebrahimi","year":"2020","journal-title":"Stem Cell Res Therapy"},{"key":"R25-20250915","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/aor.12892","article-title":"HEMOXCell, a new oxygen carrier usable as an additive for mesenchymal stem cell culture in platelet lysate-supplemented media.","volume":"41","author":"Le Pape","year":"2017","journal-title":"Artif Organs"},{"key":"R26-20250915","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.anpedi.2012.12.002","article-title":"Results of hematopoietic stem cell transplantation in hemoglobinopathies: thalassemia major and sickle cell disease.","volume":"79","author":"Hladun","year":"2013","journal-title":"An Pediatr (Barc)"},{"key":"R27-20250915","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1182\/blood-2008-05-157198","article-title":"Biologic properties and enucleation of red blood cells from human embryonic stem cells.","volume":"112","author":"Lu","year":"2008","journal-title":"Blood"},{"issue":"19","key":"R28-20250915","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1089\/neu.2015.3908","article-title":"Cerebral vasoactivity and oxygenation with oxygen carrier M101 in Rats.","volume":"34","author":"Moon-Massat","year":"2017","journal-title":"J Neurotrauma"},{"key":"R29-20250915","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00109-023-02350-3","article-title":"The artificial oxygen carrier erythrocruorin\u2014characteristics and potential significance in medicine.","volume":"101","author":"Kruczkowska","year":"2023","journal-title":"J Mol Med (Berl)"},{"issue":"12","key":"R30-20250915","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1111\/aor.13384","article-title":"PEGylated carboxyhemoglobin bovine (SANGUINATE) ameliorates myocardial infarction in a rat model.","volume":"42","author":"Kawaguchi","year":"2018","journal-title":"Artif Organs"},{"issue":"8","key":"R31-20250915","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1111\/trf.12643","article-title":"Impact of acellular hemoglobin-based oxygen carriers on brain apoptosis in rats.","volume":"54","author":"Vandegriff","year":"2014","journal-title":"Transfusion"},{"issue":"4","key":"R32-20250915","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/aor.12905","article-title":"Effect of oxygen affinity of liposome-encapsulated hemoglobin on cerebral ischemia and reperfusion as detected by positron emission tomography in nonhuman primates.","volume":"41","author":"Kawaguchi","year":"2017","journal-title":"Artif Organs"},{"key":"R33-20250915","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1227\/01.NEU.0000325493.51900.53","article-title":"Perfluorocarbon emulsions improve cognitive recovery after lateral fluid percussion brain injury in rats.","volume":"63","author":"Zhou","year":"2008","journal-title":"Neurosurgery"},{"key":"R34-20250915","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.colsurfb.2012.04.011","article-title":"Optimisation of perfluoro nano-scale emulsions: the importance of particle size for enhanced oxygen transfer in biomedical applications.","volume":"98","author":"Fraker","year":"2012","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"2","key":"R35-20250915","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/toxsci\/kfs109","article-title":"Down selection of polymerised bovine hemoglobins for use as oxygen-releasing therapeutics in a guinea pig model.","volume":"127","author":"Baek","year":"2012","journal-title":"Toxicol Sci"},{"issue":"11","key":"R36-20250915","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1007\/s00421-013-2720-x","article-title":"The intravenous perfluorocarbon emulsion Oxycyte does not increase hyperbaric oxygen-related seizures in a non-sedated swine model.","volume":"113","author":"Mahon","year":"2013","journal-title":"Eur J Appl Physiol"},{"key":"R37-20250915","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/sc.2012.135","article-title":"a) The emulsified perfluorocarbon oxycyte improves spinal cord injury in a swine model of decompression sickness.","volume":"51","author":"Mahon","year":"2013","journal-title":"Spinal Cord"},{"issue":"9","key":"R38-20250915","doi-asserted-by":"crossref","first-page":"7454","DOI":"10.1021\/nn402073n","article-title":"Nonvasoconstrictive hemoglobin particles as oxygen carriers.","volume":"7","author":"Xiong","year":"2013","journal-title":"ACS Nano"},{"issue":"3","key":"R39-20250915","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2174\/1570163811666140709110301","article-title":"Effects of perfluorocarbon dodecafluoropentane (NVX-108) on cerebral microvasculature in the healthy rat.","volume":"11","author":"Moon-Massat","year":"2014","journal-title":"Curr Drug Discov Technol"},{"issue":"8","key":"R40-20250915","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/aor.12331","article-title":"Novel hemoglobin particles--promising new-generation hemoglobin-based oxygen carriers.","volume":"38","author":"B\u00e4umler","year":"2014","journal-title":"Artif Organs"},{"issue":"4","key":"R41-20250915","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3390\/jfb5040246","article-title":"Effects of the oxygen-carrying solution OxyVita C on the cerebral microcirculation and systemic blood pressures in healthy rats.","volume":"5","author":"Abutarboush","year":"2014","journal-title":"J Funct Biomater"},{"issue":"8","key":"R42-20250915","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/aor.12304","article-title":"Biological evaluation of liposome-encapsulated hemoglobin surface-modified with a novel PEGylated nonphospholipid amphiphile.","volume":"38","author":"Yadav","year":"2014","journal-title":"Artif Organs"},{"issue":"33","key":"R43-20250915","doi-asserted-by":"crossref","first-page":"18369","DOI":"10.1021\/acsami.5b04226","article-title":"Perfluorocarbon-encapsulated PLGA-PEG emulsions as enhancement agents for highly efficient reoxygenation to cell and organism.","volume":"7","author":"Yao","year":"2015","journal-title":"ACS Appl Mater Interfaces"},{"issue":"9","key":"R44-20250915","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/jcbfm.2015.82","article-title":"The brain metabolic activity after resuscitation with liposome-encapsulated hemoglobin in a rat model of hypovolemic shock.","volume":"35","author":"Rao","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"R45-20250915","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/jfb7040029","article-title":"Cerebral microvascular and systemic effects following intravenous administration of the perfluorocarbon emulsion perftoran.","volume":"7","author":"Abutarboush","year":"2016","journal-title":"J Funct Biomater"},{"issue":"6","key":"R46-20250915","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00408-016-9941-9","article-title":"The emulsified PFC Oxycyte\u00ae improved oxygen content and lung injury score in a swine model of oleic acid lung injury (OALI).","volume":"194","author":"Haque","year":"2016","journal-title":"Lung"},{"key":"R47-20250915","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejps.2016.08.010","article-title":"Nanovesicular liposome-encapsulated hemoglobin (LEH) prevents multi-organ injuries in a rat model of hemorrhagic shock.","volume":"93","author":"Yadav","year":"2016","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"R48-20250915","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/21691401.2017.1284858","article-title":"Functionality of albumin-derived perfluorocarbon-based artificial oxygen carriers in the Langendorff-heart.","volume":"45","author":"Wrobeln","year":"2017","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"3","key":"R49-20250915","first-page":"555714","article-title":"Improved albumin-derived perfluorocarbon-based artificial oxygen carriers: in-vivo evaluation of biocompatibility.","volume":"7","author":"Wrobeln","year":"2017","journal-title":"Adv Biotech & Micro"},{"key":"R50-20250915","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejpb.2017.02.015","article-title":"Albumin-derived perfluorocarbon-based artificial oxygen carriers: a physico-chemical characterisation and first in vivo evaluation of biocompatibility.","volume":"115","author":"Wrobeln","year":"2017","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"R51-20250915","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/aor.12864","article-title":"Liposome-encapsulated hemoglobin accelerates skin wound healing in diabetic dB\/dB mice.","volume":"41","author":"Fukui","year":"2017","journal-title":"Artif Organs"},{"issue":"11","key":"R52-20250915","doi-asserted-by":"crossref","first-page":"e0207197","DOI":"10.1371\/journal.pone.0207197","article-title":"Efficacy of the perfluorocarbon dodecafluoropentane as an adjunct to pre-hospital resuscitation.","volume":"13","author":"Bonanno","year":"2018","journal-title":"PLoS One"},{"issue":"5","key":"R53-20250915","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1177\/0271678X17705567","article-title":"Pharmacologically increasing collateral perfusion during acute stroke using a carboxyhemoglobin gas transfer agent (Sanguinate\u2122) in spontaneously hypertensive rats.","volume":"38","author":"Cipolla","year":"2018","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"R54-20250915","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/aor.13071","article-title":"Preclinical in vitro safety investigations of submicron sized hemoglobin based oxygen carrier HbMP-700.","volume":"42","author":"Kao","year":"2018","journal-title":"Artif Organs"},{"issue":"10","key":"R55-20250915","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1249\/MSS.0000000000002354","article-title":"Prevention of decompression sickness by novel artificial oxygen carriers.","volume":"52","author":"Mayer","year":"2020","journal-title":"Med Sci Sports Exerc"},{"issue":"1","key":"R56-20250915","doi-asserted-by":"crossref","first-page":"11950","DOI":"10.1038\/s41598-020-68701-z","article-title":"Albumin-derived perfluorocarbon-based artificial oxygen carriers can avoid hypoxic tissue damage in massive hemodilution.","volume":"10","author":"Wrobeln","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"R57-20250915","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12868-020-00571-7","article-title":"Resuscitation with macromolecular superoxide dismutase\/catalase mimetic polynitroxylated PEGylated hemoglobin offers neuroprotection in guinea pigs after traumatic brain injury combined with hemorrhage shock.","volume":"21","author":"Seno","year":"2020","journal-title":"BMC Neurosci"},{"key":"R58-20250915","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jss.2021.05.044","article-title":"Platelet and white cell reactivity to top-load intravenous perfluorocarbon infusion in healthy sheep.","volume":"267","author":"Zhu","year":"2021","journal-title":"J Surg Res"},{"issue":"1","key":"R59-20250915","doi-asserted-by":"crossref","first-page":"25","DOI":"10.22462\/01.03.2021.3","article-title":"The effect of the perfluorocarbon emulsion Oxycyte\u2122 in an ovine model of severe decompression illness.","volume":"48","author":"Cronin","year":"2021","journal-title":"Undersea Hyperb Med"},{"issue":"1","key":"R62-20250915","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1213\/ANE.0000000000003957","article-title":"Blood substitutes and oxygen therapeutics: a review.","volume":"132","author":"Jahr","year":"2021","journal-title":"Anesth Analg"},{"issue":"2","key":"R64-20250915","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3390\/medicina59020396","article-title":"Hemoglobin-based oxygen carriers: where are we now in 2023?","volume":"59","author":"Chen","year":"2023","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"R65-20250915","doi-asserted-by":"crossref","first-page":"103016","DOI":"10.1016\/j.transci.2020.103016","article-title":"Mini-review on the properties and possible applications of therapeutic oxygen carrier Hemarina-M101.","volume":"60","author":"Varney","year":"2021","journal-title":"Transfus Apher Sci"},{"key":"R66-20250915","doi-asserted-by":"crossref","first-page":"110421","DOI":"10.1016\/j.mehy.2020.110421","article-title":"Combating hypoxemia in COVID-19 patients with a natural oxygen carrier, HEMO2Life\u00ae (M101).","volume":"146","author":"Lupon","year":"2021","journal-title":"Med Hypotheses"},{"issue":"9","key":"R67-20250915","first-page":"1009","article-title":"Hemospan: a hemoglobin-based oxygen carrier for potential use as a blood substitute and for the potential treatment of critical limb ischemia.","volume":"9","author":"Smani","year":"2008","journal-title":"Curr Opin Investig Drugs"},{"key":"R69-20250915","doi-asserted-by":"crossref","first-page":"707797","DOI":"10.3389\/fchem.2021.707797","article-title":"Stability of maleimide-PEG and mono-sulfone-PEG conjugation to a novel engineered cysteine in the human hemoglobin alpha subunit.","volume":"9","author":"Cooper","year":"2021","journal-title":"Front Chem"},{"issue":"3","key":"R70-20250915","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2174\/157016312802650742","article-title":"Cross-linked, polymerised, and PEG-conjugated hemoglobin-based oxygen carriers: clinical safety and efficacy of recent and current products.","volume":"9","author":"Jahr","year":"2012","journal-title":"Curr Drug Discov Technol"},{"issue":"7","key":"R71-20250915","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1097\/00003246-200007000-00017","article-title":"A phase I study of oxidised raffinose cross-linked human hemoglobin.","volume":"28","author":"Carmichael","year":"2000","journal-title":"Crit Care Med"},{"issue":"3","key":"R73-20250915","first-page":"287","article-title":"Alternatives to transfusion.","volume":"153","author":"Bachert","year":"2020","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"R75-20250915","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/00003246-198502000-00008","article-title":"Pulmonary complications after fluosol administration to patients with life-threatening blood loss.","volume":"13","author":"Police","year":"1985","journal-title":"Crit Care Med"},{"issue":"4","key":"R76-20250915","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3390\/jfb2040414","article-title":"Molecular design properties of OxyVita hemoglobin, a new generation therapeutic oxygen carrier: a review.","volume":"2","author":"Harrington","year":"2011","journal-title":"J Funct Biomater"},{"issue":"3","key":"R77-20250915","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2174\/157016312802650797","article-title":"ATP-adenosine-glutathione cross-linked hemoglobin as clinically useful oxygen carrier.","volume":"9","author":"Simoni","year":"2012","journal-title":"Curr Drug Discov Technol"},{"issue":"Supplement 2","key":"R78-20250915","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.mat.0000840828.14837.ae","article-title":"Recent status of development of Hb-based blood substitute with pharmacologic properties of ATP, adenosine and reduced glutathione.","volume":"68","author":"Simoni","year":"2022","journal-title":"ASAIO J"},{"issue":"3","key":"R79-20250915","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/jfb8030024","article-title":"Biocompatibility of HbV: liposome-encapsulated hemoglobin molecules-liposome effects on immune function.","volume":"8","author":"Azuma","year":"2017","journal-title":"J Funct Biomater"},{"key":"R80-20250915","doi-asserted-by":"crossref","first-page":"346","DOI":"10.5966\/sctm.2013-0054","article-title":"Concise review: stem cell-based approaches to red blood cell production for transfusion.","volume":"3","author":"Shah","year":"2014","journal-title":"Stem Cells Transl. Med"},{"issue":"1","key":"R81-20250915","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12951-024-03060-9","article-title":"Therapeutic delivery of oxygen using artificial oxygen carriers demonstrates the possibility of treating a wide range of diseases.","volume":"23","author":"Mohanto","year":"2025","journal-title":"J Nanobiotechnol"},{"issue":"3730","key":"R82-20250915","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1126\/science.152.3730.1755","article-title":"Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure.","volume":"152","author":"Clark","year":"1966","journal-title":"Science"},{"issue":"1","key":"R83-20250915","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.1038\/s41598-021-84076-1","article-title":"Quality by design approach identifies critical parameters driving oxygen delivery performance in vitro for perfluorocarbon based artificial oxygen carriers.","volume":"11","author":"Lambert","year":"2021","journal-title":"Sci Rep"},{"issue":"2","key":"R84-20250915","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00424-020-02482-2","article-title":"Perfluorocarbon-based oxygen carriers: from physics to physiology.","volume":"473","author":"J\u00e4gers","year":"2021","journal-title":"Pflugers Arch"},{"issue":"6","key":"R85-20250915","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1097\/00000542-200212000-00004","article-title":"Use of perflubron emulsion to decrease allogeneic blood transfusion in high-blood-loss non-cardiac surgery: results of a European phase 3 study.","volume":"97","author":"Spahn","year":"2002","journal-title":"Anesthesiology"},{"key":"R86-20250915","doi-asserted-by":"crossref","first-page":"102407","DOI":"10.1016\/j.cis.2021.102407","article-title":"Therapeutic oxygen delivery by perfluorocarbon-based colloids.","volume":"294","author":"Krafft","year":"2021","journal-title":"Adv Colloid Interface Sci"},{"issue":"1","key":"R87-20250915","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1525-1594.1984.tb04238.x","article-title":"Surgical use of fluosol-DA in Jehovah\u2019s Witness patients.","volume":"8","author":"Ohyanagi","year":"1984","journal-title":"Artif Organs"},{"issue":"9","key":"R88-20250915","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1021\/cr970143c","article-title":"Oxygen carriers (\u201cblood substitutes\u201d)\u2014raison d\u2019etre, chemistry, and some physiology.","volume":"101","author":"Riess","year":"2001","journal-title":"Chem Rev"},{"issue":"1","key":"R89-20250915","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jatmed.2024.02.003","article-title":"Perfluorocarbon-based oxygen carriers: what is new in 2024?","volume":"3","author":"Zhao","year":"2024","journal-title":"J Anesth Transl Med"},{"issue":"3","key":"R90-20250915","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s40005-024-00665-y","article-title":"Perfluorocarbon-based artificial oxygen carriers for red blood cell substitutes: considerations and direction of technology.","volume":"54","author":"Kim","year":"2024","journal-title":"J Pharm Invest"},{"issue":"11-12","key":"R91-20250915","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1007\/s00421-019-04252-0","article-title":"Perfluorocarbons for the treatment of decompression illness: how to bridge the gap between theory and practice.","volume":"119","author":"Mayer","year":"2019","journal-title":"Eur J Appl Physiol"},{"issue":"2","key":"R92-20250915","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1124\/jpet.118.254664","article-title":"Artificial oxygen carriers-past, present, and future-a review of the most innovative and clinically relevant concepts.","volume":"369","author":"Ferenz","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"R93-20250915","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/1573413052953110","article-title":"Nanosystems in drug targeting: opportunities and challenges.","volume":"1","author":"Vasir","year":"2005","journal-title":"Curr Nanosci"},{"issue":"12","key":"R95-20250915","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/ejoc.202100154","article-title":"Strategic synthesis of \u201cpicket fence\u201d porphyrins based on nonplanar macrocycles.","volume":"2021","author":"Norvai\u0161a","year":"2021","journal-title":"European J Org Chem"},{"key":"R96-20250915","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s40005-021-00549-5","article-title":"Recent progress in hydrophobic ion-pairing and lipid-based drug delivery systems for enhanced oral delivery of biopharmaceuticals.","volume":"52","author":"Noh","year":"2022","journal-title":"J Pharm Investig"},{"issue":"5","key":"R97-20250915","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1021\/bc070086m","article-title":"O2-binding albumin thin films: solid membranes of poly(ethylene glycol)-conjugated human serum albumin incorporating iron porphyrin.","volume":"18","author":"Nakagawa","year":"2007","journal-title":"Bioconjug Chem"},{"issue":"9","key":"R98-20250915","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.3390\/molecules23092210","article-title":"Oxygen-carrying micro\/nanobubbles: composition, synthesis techniques and potential prospects in photo-triggered theranostics.","volume":"23","author":"Khan","year":"2018","journal-title":"Molecules"},{"issue":"12","key":"R99-20250915","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.7150\/thno.4410","article-title":"Theranostic oxygen delivery using ultrasound and microbubbles.","volume":"2","author":"Kwan","year":"2012","journal-title":"Theranostics"},{"key":"R100-20250915","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jconrel.2015.04.027","article-title":"Therapeutic gas delivery via microbubbles and liposomes.","volume":"209","author":"Fix","year":"2015","journal-title":"J Control Release"}],"container-title":["Blood Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BS9.0000000000000249","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T15:01:14Z","timestamp":1757948474000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BS9.0000000000000249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":91,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/bs9.0000000000000249","relation":{},"ISSN":["2543-6368"],"issn-type":[{"value":"2543-6368","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,12]]}}}